AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Clipboard and stethoscope

5 physician leaders on what comes next in healthcare

| 10 Min Read
Four people stand at winding paths

Lifelong learning for physicians enters a new chapter

| 4 Min Read
Weight lifter

This doctor’s journey to lifestyle medicine started at the gym

| 6 Min Read
Two feet, one of them injured and bandaged, with a walking cane

Review in internal medicine: 8 drivers of orthostatic hypotension

| 4 Min Read